Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Acrotech Biopharma Inc

Home Clinical Trial Sponsors and OrganizationsAcrotech Biopharma Inc

Acrotech Biopharma Inc

279 Princeton Hightstown Rd, East Windsor, New Jersey, United States

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

30

1 active

Approvals

17

Total approvals

Agencies

2

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 1

19

63.3%

Phase 2

6

20.0%

Phase 3

4

13.3%

Trial Status Distribution

Active, not recruiting

1

3.3%

Completed

22

73.3%

Recruiting

3

10.0%

Terminated

1

3.3%

Unknown

1

3.3%

Withdrawn

2

6.7%

Clinical Trials

Trials sponsored by this organization (30)

A Phase 3 study to evaluate safety and efficacy of the combination of for Bel- CHOP/ Fol-COP drugs against CHOP in newly diagnosed Peripheral T-Cell Lymphoma (blood cancer) patients

Active, not recruiting

Mar 2024499 participants

To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCL

Oct 2023504 participants

Study to Evaluate the Pharmacokinetics and Safety of Pralatrexate in Patients With Advanced Solid Tumor or Hematological Malignancy and Either Normal Hepatic Function or Mild, Moderate, or Severe Hepatic Impairment

Dec 202224 participants

This Study is to Assess the Efficacy of Difamilast Ointment in Mild to Moderate Atopic Dermatitis(AD)

Oct 2022153 participants

A Open-label Study to Assess the Long-term Safety of Difamilast Ointment 1% in Mild to Moderate Atopic Dermatitis

Sep 2022542 participants

PK Study on Ready-to-Use Injection (VSLI-RTU) 1 Vial & 3 Vial Formulation Marqibo® in Hematological Malignant Patients

Aug 202056 participants

Extension Study for Patients Who Had Not Met Criteria for Discontinuation in Previous Sponsored Belinostat Trials

Aug 20198 participants

Establish the PK of Belinostat in Patients With Wild-type, Heterozygous, and Homozygous UGT1A1*28 Genotypes

Apr 201617 participants

Page 1 of 4

Approvals

Approvals by Agency

NMPA

National Medical Products Administration

2

Approvals

FDA

Food and Drug Administration

15

Approvals

Recent Approvals

Melphalan Hydrochloride for Injection

News

No news articles found

On this page

Overview
Clinical Trials30
Approvals17
News

Back to Organizations